METTL1 and posterior cortical atrophy: Notably, the m7G modification, catalyzed by METTL1 and WDR4 on tRNA, is markedly increased in cancer patients, affecting a range of malignancies including AML, HCC, prostate cancer (PCa), and bladder cancer [71, 72, 126–128].